Michael Culme-Seymour is Marken's new APAC VP
Australia | Influencers | By BioSpectrum Bureau | 2 Comment | 04 Oct, 2013
‎Singapore: Supply chain firm, Marken has appointed Mr Michael Culme-Seymour as VP, Asia Pacific, effective Octobe...Read more
Australian firm MiReven signs deal with Silence Theraeutics
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Aug, 2012
Singapore: Silence Therapeutics, a leading RNA interference (RNAi) therapeutics company based in the UK, has signed an a...Read more
Allied Herpes vaccine progresses to phase I
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Jun, 2013
Singapore: Allied Healthcare has announced that its Herpes Simplex Virus (HSV-2) vaccine has received ethical approval t...Read more
Aus, US universities give birth to cancer company
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 Dec, 2012
Singapore: UniQuest has partnered with US-based Emory University to package biotech assets for a new start-up company fr...Read more
Burnet director takes up key international vaccine position
Australia | News | By BioSpectrum Bureau | 0 Comment | 14 Sep, 2012
Singapore: The director and CEO of Australia's largest virology and communicable disease research center, Burnet Institu...Read more
Aus vaccine firm helps US army fight bio-terrorism
Australia | News | By BioSpectrum Bureau | 0 Comment | 15 Feb, 2013
Singapore: Australian infectious disease therapy and vaccine development company BioDiem's novel antimicrobial (BDM-I) w...Read more
Martin Cross is new chair of Medicines Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 26 Jun, 2013
Singapore: The Board of Medicines Australia has announced that Dr Martin Cross has been appointed as the new chair of Me...Read more
Australia to grow Chinese anti-cancer fruit
Australia | News | By BioSpectrum Bureau | 0 Comment | 13 Dec, 2012
Singapore: University of Queensland (UQ) is soon going to globally launch a delicious berry-like ancient Chinese red bay...Read more
Drug to help cancer children down under
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 22 Jul, 2014
Singapore: Two months after Leicestershire company Nova Laboratories received US approval to sell Xaluprine in the count...Read more
Fisher&Paykel appoints Atcor's chairman as its director
Australia | News | By BioSpectrum Bureau | 0 Comment | 30 Oct, 2012
Singapore: Fisher & Paykel Healthcare has appointed Mr Donal O'Dwyer as an additional non-executive director of the...Read more
Osprey enrolls first patient for Cincor study
Australia | News | By BioSpectrum Bureau | 0 Comment | 21 Mar, 2013
Singapore: Australia's Osprey Medical has enrolled the first patient in Cincor IDE clinical study at the Leipzig Heart C...Read more
Bionomics Chairman Chris Fullerton to retire
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Oct, 2012
Singapore: Mr Chris Fullerton, chairman of Australian firm Bionomics, will retire from the board of Bionomics, effective...Read more
Agenix acquires diagnostics technology from Tyrian
Australia | News | By BioSpectrum Bureau | 0 Comment | 29 Oct, 2012
Singapore: Agenix has entered an agreement with Tyrian Diagnostics to license its rapid point-of-care human diagnostic ...Read more
QRx Pharma gets FDA inputs on Moxduo
Australia | News | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2013
Singapore: Australia-based QRxPharma is proceeding with US FDA to discuss the company's Moxduo new drug application (NDA...Read more
Omega XL slows Alzheimer's: Great HealthWorks study
Australia | News | By BioSpectrum Bureau | 0 Comment | 25 May, 2012
Singapore: According to a latest study published online in Neurology, omega-3 fatty acids, like those found in Omega XL ...Read more
Agilent helps Univ of Sydney in water, food research
Australia | News | By BioSpectrum Bureau | 0 Comment | 17 May, 2013
Singapore: Agilent Technologies extended its collaboration with the University of Sydney, Australia, by providing advanc...Read more
PolyActiva gets $9.53 mn Series B venture funding
Australia | News | By BioSpectrum Bureau | 0 Comment | 19 Feb, 2013
Singapore: PolyActiva raised $9.53 million (AUD $9.2 million) in a Series B financing round from a consortium of investo...Read more
ElectroCore GammaCore therapy gets Aus TGA nod
Australia | News | By BioSpectrum Bureau | 0 Comment | 20 Feb, 2013
Singapore: ElectroCore's GammaCore therapy has been approved for commercial sale by the Therapeutic Goods Administratio...Read more